These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31454306)

  • 1. Gauging the epidemic potential of a widely circulating non-invasive meningococcal strain in Africa.
    Brynildsrud OB; Eldholm V; Rakhimova A; Kristiansen PA; Caugant DA
    Microb Genom; 2019 Aug; 5(8):. PubMed ID: 31454306
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular insights into meningococcal carriage isolates from Burkina Faso 7 years after introduction of a serogroup A meningococcal conjugate vaccine.
    Topaz N; Kristiansen PA; Schmink S; Congo-Ouédraogo M; Kambiré D; Mbaeyi S; Paye M; Sanou M; Sangaré L; Ouédraogo R; Wang X
    Microb Genom; 2020 Dec; 6(12):. PubMed ID: 33332261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine.
    MenAfriCar consortium
    J Infect Dis; 2015 Oct; 212(8):1298-307. PubMed ID: 25858956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine.
    Bårnes GK; Kristiansen PA; Beyene D; Workalemahu B; Fissiha P; Merdekios B; Bohlin J; Préziosi MP; Aseffa A; Caugant DA
    BMC Infect Dis; 2016 Nov; 16(1):639. PubMed ID: 27814682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.
    Kristiansen PA; Ba AK; Ouédraogo AS; Sanou I; Ouédraogo R; Sangaré L; Diomandé F; Kandolo D; Saga IM; Misegades L; Clark TA; Préziosi MP; Caugant DA
    BMC Infect Dis; 2014 Dec; 14():663. PubMed ID: 25472422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hierarchical genomic analysis of carried and invasive serogroup A Neisseria meningitidis during the 2011 epidemic in Chad.
    Diallo K; Gamougam K; Daugla DM; Harrison OB; Bray JE; Caugant DA; Lucidarme J; Trotter CL; Hassan-King M; Stuart JM; Manigart O; Greenwood BM; Maiden MCJ
    BMC Genomics; 2017 May; 18(1):398. PubMed ID: 28532434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine.
    Kristiansen PA; Ba AK; Sanou I; Ouédraogo AS; Ouédraogo R; Sangaré L; Diomandé F; Kandolo D; Thomas JD; Clark TA; Laforce M; Caugant DA
    BMC Infect Dis; 2013 Aug; 13():363. PubMed ID: 23914778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole genome sequencing reveals within-host genetic changes in paired meningococcal carriage isolates from Ethiopia.
    Bårnes GK; Brynildsrud OB; Børud B; Workalemahu B; Kristiansen PA; Beyene D; Aseffa A; Caugant DA
    BMC Genomics; 2017 May; 18(1):407. PubMed ID: 28545446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights on Population Structure and Within-Host Genetic Changes among Meningococcal Carriage Isolates from U.S. Universities.
    Joseph SJ; Topaz N; Chang HY; Whaley MJ; Vuong JT; Chen A; Hu F; Schmink SE; Jenkins LT; Rodriguez-Rivera LD; Thomas JD; Acosta AM; McNamara L; Soeters HM; Mbaeyi S; Wang X
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32269159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Epidemiology of Hypervirulent Serogroup W, ST-11 Neisseria meningitidis.
    Mustapha MM; Marsh JW; Krauland MG; Fernandez JO; de Lemos AP; Dunning Hotopp JC; Wang X; Mayer LW; Lawrence JG; Hiller NL; Harrison LH
    EBioMedicine; 2015 Oct; 2(10):1447-55. PubMed ID: 26629539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal carriage by age in the African meningitis belt: a systematic review and meta-analysis.
    Cooper LV; Kristiansen PA; Christensen H; Karachaliou A; Trotter CL
    Epidemiol Infect; 2019 Jan; 147():e228. PubMed ID: 31364554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa.
    Ganesh K; Allam M; Wolter N; Bratcher HB; Harrison OB; Lucidarme J; Borrow R; de Gouveia L; Meiring S; Birkhead M; Maiden MC; von Gottberg A; du Plessis M
    BMC Microbiol; 2017 Feb; 17(1):40. PubMed ID: 28222677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa.
    Brynildsrud OB; Eldholm V; Bohlin J; Uadiale K; Obaro S; Caugant DA
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5510-5515. PubMed ID: 29735685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence and genomic diversification of a virulent serogroup W:ST-2881(CC175)
    Lamelas A; Hauser J; Dangy JP; Hamid AM; Röltgen K; Abdul Sater MR; Hodgson A; Sie A; Junghanss T; Harris SR; Parkhill J; Bentley SD; Pluschke G
    Microb Genom; 2017 Aug; 3(8):e000120. PubMed ID: 29026659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
    Xie O; Pollard AJ; Mueller JE; Norheim G
    Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narrative review of methods and findings of recent studies on the carriage of meningococci and other Neisseria species in the African Meningitis Belt.
    Greenwood BM; Aseffa A; Caugant DA; Diallo K; Kristiansen PA; Maiden MCJ; Stuart JM; Trotter CL
    Trop Med Int Health; 2019 Feb; 24(2):143-154. PubMed ID: 30461138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal carriage in the African meningitis belt.
    MenAfriCar Consortium
    Trop Med Int Health; 2013 Aug; 18(8):968-78. PubMed ID: 23682910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].
    Daugla DM; Gami JP; Gamougam K; Naibei N; Mbainadji L; Narbé M; Toralta J; Kodbesse B; Ngadoua C; Coldiron ME; Fermon F; Page AL; Djingarey MH; Hugonnet S; Harrison OB; Rebbetts LS; Tekletsion Y; Watkins ER; Hill D; Caugant DA; Chandramohan D; Hassan-King M; Manigart O; Nascimento M; Woukeu A; Trotter C; Stuart JM; Maiden M; Greenwood BM
    Lancet; 2014 Jan; 383(9911):40-47. PubMed ID: 24035220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
    Mueller JE; Borrow R; Gessner BD
    Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.
    Mohammed I; Iliyasu G; Habib AG
    Pathog Glob Health; 2017 Feb; 111(1):1-6. PubMed ID: 28081671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.